M62.59
Muscle wasting and atrophy, not elsewhere classified, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code M62.59 pertains to muscle wasting and atrophy that occur across various parts of the body. This condition involves a significant loss of muscle tissue, leading to weakness and reduced physical function. Unlike localized muscle atrophy, this type impacts multiple muscle groups, making daily activities more challenging. Recognizing the characteristics, causes, and potential management approaches can help in understanding this complex health issue.
Causes & Symptoms
Clinical Causes: Chronic illnesses such as cancer, kidney disease, or heart failure Neurological disorders like amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS) Prolonged bed rest or immobility Malnutrition or vitamin deficiencies Endocrine disorders such as hypothyroidism or diabetes Musculoskeletal conditions like severe arthritis or rotator cuff injuries Use of certain medications, including corticosteroids Aging, which naturally leads to muscle mass reduction
Key Symptoms: Noticeable decrease in muscle size and strength Muscle weakness that affects daily tasks Fatigue during physical activity Poor coordination and balance Muscle cramps or pain Difficulty performing routine movements or tasks Postural changes due to weakened muscles Overall decreased physical endurance
Diagnostic & Treatment
Diagnosis Path: Diagnosing muscle wasting and atrophy involves a comprehensive clinical assessment, including a detailed medical history and physical examination. Healthcare providers may utilize various diagnostic tests such as:
Treatment Protocols: Appropriate management of muscle wasting and atrophy hinges on addressing the underlying cause. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is M62.59 a billable ICD-10 code?
Yes, M62.59 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M62.59?
Clinical documentation must specify the nature of Muscle wasting and atrophy, not elsewhere classified, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference